Clinical Trial Update: Ezetrol Post-Marketing Study [Phase 4]

View source ↗

Summary

Phase 4 post-marketing study of Ezetrol (ezetimibe) for hyperlipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• Ezetrol (ezetimibe)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hyperlipidemia | Phase 4 | Status: COMPLETED